Total Funding
76
43
Total FundingPost-IPO Equity raised
Growth Score
-17 pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58633
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
- Chris Ehrlich: CEOPast Role: Locust Walk Partners, Chief Executive Officer
- Daniel Corey: Founder and Chief Scientific Officer
About the Company
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
